Tapinarof: all 34 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell LymphomaNot yet recruitingNCT07658924Phase 2
- Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque PsoriasisNot yet recruitingNCT07635043Phase 4
- Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
- Tapinarof for Cutaneous Lupus ErythematosusEnrolling by invitationNCT06661213Early Phase 1
- Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)Enrolling by invitationNCT05981118Phase 2/3
- A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck RegionCompletedNCT05789576Phase 4Results posted
- A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque PsoriasisCompletedNCT05680740Phase 4Results posted
- Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic DermatitisCompletedNCT05186805Phase 2Results posted
- Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic DermatitisCompletedNCT05142774Phase 3Results posted
- Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)CompletedNCT05032859Phase 3Results posted
- Tapinarof for the Treatment of Atopic Dermatitis in Children and AdultsCompletedNCT05014568Phase 3Results posted
- Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)CompletedNCT04053387Phase 3Results posted
- Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque PsoriasisCompletedNCT04042103Phase 2Results posted
- Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)CompletedNCT03983980Phase 3Results posted
- Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)CompletedNCT03956355Phase 3Results posted
- A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)CompletedNCT02564055Phase 2Results posted
- A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque PsoriasisCompletedNCT02564042Phase 2Results posted
- A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.CompletedNCT07546214Phase 1
- A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic DermatitisSuspendedNCT07265479Phase 3
- Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque PsoriasisCompletedNCT06742957Phase 3
- Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar KeratodermaActive, not recruitingNCT06561321Phase 2
- Vtama in Psoriasis Patients Being Treated With Biologics.CompletedNCT06103695Phase 4
- Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic DermatitisStatus unknownNCT05326672Phase 3
- Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate PsoriasisStatus unknownNCT05326659Not applicable
- Tapinarof for the Treatment of Plaque Psoriasis in Pediatric SubjectsActive, not recruitingNCT05172726Phase 3
- Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in AdultsStatus unknownNCT05064748Phase 4
- GSK2894512 Vehicle-Controlled Study for Adult Plaque PsoriasisWithdrawnNCT03202004Phase 3
- A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult SubjectsWithdrawnNCT03201978Phase 1
- Skin Irritation Study of GSK2894512 CreamCompletedNCT02637206Phase 1
- Pharmacokinetic Study of Topical GSK2894512 CreamCompletedNCT02466152Phase 1
- A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy SubjectsCompletedNCT01984775Phase 1
- Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 CreamCompletedNCT01098734Phase 2
- A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeksCompletedNCT01098721Phase 2
- Phase IIa Study of WBI-1001 Cream for Atopic DermatitisCompletedNCT00837551Phase 1/2